M&G PLC Bristol Myers Squibb CO Transaction History
M&G PLC
- $16.6 Billion
- Q2 2025
A detailed history of M&G PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, M&G PLC holds 6,788,125 shares of BMY stock, worth $312 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
6,788,125
Previous 6,856,139
0.99%
Holding current value
$312 Million
Previous $418 Million
24.86%
% of portfolio
1.89%
Previous 2.88%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.58BCall Options Held
26.1MPut Options Held
23.8M-
Vanguard Group Inc Valley Forge, PA195MShares$8.95 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.96 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.25 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...